MI-519-64

N/A

Report date: 2022/03/23 11:22:46
NME

Base Information

Drug NameMI-519-64
Drug Alias NameMI-519-64
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of MichiganAscentage Pharma Group International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAscentage Pharma Group InternationalSanofi
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A